| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $368K | -75.3% |
| Cost of Revenue | $536K | -56.2% |
| R&D Expense | $11.3M | -11.5% |
| SG&A Expense | $11.4M | +4.7% |
| Operating Income | -$22.8M | +2.2% |
| Pre-tax Income | -$33.3M | -46.1% |
| Net Income | -$33.3M | -46.1% |
| EPS (Basic) | -$2521.41 | — |
| EPS (Diluted) | -$2521.41 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Short-term Investments | $4.6M | +0.0% |
| Inventory | $150K | — |
| Current Assets | $25.6M | +170.1% |
| Total Assets | $30.1M | +130.9% |
| Current Liabilities | $3.4M | +65.3% |
| Total Liabilities | $31.1M | +1198.6% |
| Stockholders' Equity | -$1.0M | -109.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$19.2M | +1.4% |
| Capital Expenditures | $1.1M | +0.5% |
| Investing Cash Flow | $2.9M | -53.9% |
| Financing Cash Flow | $36.3M | +492.8% |
| Free Cash Flow | -$20.2M | +1.3% |
| — |